NCT07582978Not yet recruiting
Impact of the Procurement Technique on Outcomes After Liver Transplantation
Impact of the Procurement Technique on Outcomes After Liver Transplantation: a French Multicenter Prospective Study
Source: ClinicalTrials.gov · Last updated 13 May 2026
Brief summary (registry, in English)
Liver transplantation (LT) is the standard treatment for hepatocellular carcinoma (HCC) and end-stage liver disease, with excellent long-term outcomes despite the increasing use of extended criteria donors due to organ shortage. As traditional evaluation criteria have become insufficient, new indicators such as Arterial and Biliary Complication-Free Survival (ABCFS) have been developed to better assess post-transplant outcomes. Primary objective: To assess, in a large-scale study, whether the procurement technique influences liver transplantation outcomes in terms of arterial and biliary complication-free survival.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 1810 (estimated)
- First submitted
- 28 Apr 2026
- Start date
- Sept 2026
- Primary completion date
- Sept 2031
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Diseases
- Liver and biliary tract cancer
- NCT number
- NCT07582978
What you commit to
- Study type: Observational
- Planned participants: 1810
- From Sept 2026 to the primary completion date, Sept 2031
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Multiorgan transplantation
- Split liver transplantation (shared grafts)
- Domino transplantation (no actual organ procurement in the conventional sense)
Other
- Pancreas procurement
- Retransplantation
- Patient refusal to allow the use of their data
Who the study is looking for
- Patients aged 18 years or older at the time of inclusion
- Listed on the national waiting list of the Agence de la Biomédecine (ABM)
- Undergoing a first liver transplantation in France
- Receiving a whole liver graft
- No prior or subsequent transplantation of another organ
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.